AI briefing: Hyped AI goes to the hospital | Is healthcare AI sustainable? | US & Israel power up AI partnership | more

United Imaging AI promotion RSNA 2023

A splashy AI promotion invites visitors into a booth at the RSNA conference in Chicago. Photo by Dave Fornell 

Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. 

Missouri becomes latest plaintiff in lawsuits against PBMs, drug companies over skyrocketing insulin prices

Missouri state house capitol Jefferson City

The Missouri State Capitol building in Jefferson City

The Missouri complaint mirrors those brought by the Federal Trade Commission, the state of Texas and Philadelphia-based Jefferson Health, among others, in that it’s focused on alleged collusion between pharmacy benefit managers and drug companies to control the price of insulin. 

FDA issues warning over use of Boston Scientific stents after 167 injuries, 3 deaths

warning safety alert recall healthcare issue

Boston Scientific sent all known customers a letter on December 19, 2025 alerting them to an issue with certain AXIOS Stent and Electrocautery Enhanced Delivery Systems. During deployment, the stents may not expand. This can cause severe, potentially life-threatening injury to patients. All recalled stents must be removed from clinical settings immediately.